Showing results (911-920 of 1,007) with videos related to

Sort By:
Pageof 101
Cadernos De Saude Publica|January 31, 2009
[Association between mode of delivery and maternal complications in a public hospital in Greater Metropolitan São Paulo, Brazil]Luís Carlos Machado Junior, Christian Eric Sevrin, Emerson de Oliveira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2022
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trialsJ L Perez-Gracia, N Penel, E Calvo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast CancerSara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, et al.
NPJ Breast Cancer|September 22, 2021
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancerAndrea Gombos, David Venet, Lieveke Ameye, et al.
Scientific Reports|July 15, 2022
Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticlesDorota Lubanska, Sami Alrashed, Gage T Mason, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023Bojana Milojkovic Kerklaan, Bojana Milojkovic Kerklaan, Veronique Diéras, et al.
International Journal of Molecular Sciences|September 25, 2019
Unravelling the Metabolic and Hormonal Machinery During Key Steps of Somatic Embryogenesis: A Case Study in CoffeeRayan Awada, Claudine Campa, Estelle Gibault, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2024
Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic CancerEric Van Cutsem, Joelle Collignon, Rikke L Eefsen, et al.
Investigational New Drugs|August 9, 2023
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational studyRebecca Kristeleit, Alexandra Leary, Jean Pierre Delord, et al.
ESMO Open|April 9, 2025
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphomaU M Lauer, A Awada, S Postel-Vinay, et al.
Pageof 101